Loading provider…
Loading provider…
Hematology & Oncology Physician in Duarte, CA
NPI: 1154641421Primary Employer
City of Hope Medical - San Bernardino Radiation Oncology
cityofhope.org
HQ Phone
Mobile
Get M.D. Aileen's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2009 - 2025
NY State Medical License
2010 - 2015

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Westchester Medical Center
Fellowship • Hematology and Medical Oncology
2011 - 2014
Richmond University Medical Center
Residency • Internal Medicine
2007 - 2010
Ross University School of Medicine
Medical School
Until 2007
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 63 | 113 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 61 | 106 |
| 3 | 96413Infusion of chemotherapy into a vein up to 1 hour | 51 | 143 |
| 4 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 43 | 309 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 36 | 43 |
Authors: Gaurav Gulati
Journal: Crit Care Med
Ibrutinib for B cell malignancies
Authors: Aileen Novero, Pavan M Ravella, Yamei Chen, George Dous, Delong Liu
Authors: Rohini Vanga, Rupa Mukherjee, Daniel Leffler, Javier Villafuerte Galvez, Kumar Pallav
Journal: Gastroenterology
Publication Date: 2013-01-24
Lead Sponsor: Karyopharm Therapeutics Inc
Intervention / Treatment: DRUG: Placebo matching for Selinexor (continuous therapy), DRUG: Selinexor (combination therapy), DRUG: Placebo matching for Selinexor (combination therapy), DRUG: Rituximab (combination therapy), DRUG: Gemcitabine (combination therapy), DRUG: Dexamethasone (combination therapy), DRUG: Cisplatin (combination therapy), DRUG: Selinexor (continuous therapy)